First, previous studies have demonstrated that the expression of both retinal VEGF mRNA [23] and ICAM-1 [30] were upregulated in rodent models of diabetic retinopathy and ICAM-1 levels were decreased by suppressing VEGF activity associated with a decrease in BRB breakdown and leukostasis [31]. Here, ICAM1 is linked to diabetic retinopathy.